Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic Test Determines Aggressiveness of Neuroblastomas

13.11.2006
Neuroblastoma is among the types of cancer that particularly often affect children. Between one and three girls and boys in 100,000 are diagnosed with this growth of the nervous system before age 14. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the University of Cologne have developed a method, based on the gene activity of tumor cells, for assessing the aggressiveness of neuroblastomas right at the time of diagnosis.

Neuroblastoma is unique in the sense that at least ten percent of tumors regress spontaneously without treatment, even if they have already started to metastasize. “Neuroblastoma takes a very variable course. In some cases, the tumor disappears by itself, while other patients die in spite of intensive treatment,” explains Dr. Frank Westermann of the Tumorgenetics Division headed by Professor Dr. Manfred Schwab. “Using our test it will be possible to assess the individual patient’s risk more accurately.” This will enable scientists not only to better customize treatment to the individual case, but also to save patients with favorable prognosis the unnecessary strain of chemotherapy.

In the largest neuroblastoma study worldwide, Dr. Westermann and Dr. Benedikt Brors of the DKFZ, jointly with Dr. Matthias Fischer of Cologne University, have investigated tumor material of 251 patients. The research project was supported by the National Genome Research Network (NGFN) and the German Cancer Aid (Deutsche Krebshilfe). The scientists identified, at first in 77 tumors, 144 genes whose activity is characteristic for the course of the disease. Some of these genes are active in neuroblastomas that tend to be more malignant, while others are read more intensively in relatively benign tumors. Using a gene chip (microarray), the scientists can now study these gene activities in tumor samples and subsequently predict the further course of the disease.

The investigators tested the gene chip in another 174 tumor samples. The genetic test proved to be highly reliable: The course of the disease was predicted with 93 percent accurateness. This is substantially better than with current methods of neuroblastoma classification. In addition, the genetic test was able to filter out patients who would not have been treated according to conventional categorization, but whose disease took an unexpectedly aggressive course. In these cases, early treatment could be life-saving.

Julia Rautenstrauch | alfa
Further information:
http://www.dkfz.de

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

When corals eat plastics

24.05.2018 | Ecology, The Environment and Conservation

Surgery involving ultrasound energy found to treat high blood pressure

24.05.2018 | Medical Engineering

First chip-scale broadband optical system that can sense molecules in the mid-IR

24.05.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>